PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 140 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $59,000 | +118.5% | 1,000 | +150.0% | 0.03% | +100.0% |
Q1 2018 | $27,000 | -44.9% | 400 | -20.0% | 0.02% | -44.4% |
Q4 2017 | $49,000 | -18.3% | 500 | 0.0% | 0.03% | -25.0% |
Q3 2017 | $60,000 | -31.0% | 500 | -50.0% | 0.04% | -33.3% |
Q2 2017 | $87,000 | +55.4% | 1,000 | -33.3% | 0.05% | +58.8% |
Q1 2017 | $56,000 | +273.3% | 1,500 | +200.0% | 0.03% | +277.8% |
Q4 2016 | $15,000 | -72.2% | 500 | -37.5% | 0.01% | -75.0% |
Q3 2016 | $54,000 | +20.0% | 800 | -46.7% | 0.04% | +9.1% |
Q2 2016 | $45,000 | – | 1,500 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |